Association between antipsychotic agents and risk of acute respiratory failure in patients with chronic obstructive pulmonary disease

JAMA Psychiatry

Volumn 74, Issue 3, 2017, Pages 252-260

  Wang, Meng Ting ^a   Tsai, Chen Liang ^b   Lin, Chen Wei ^a   Yeh, Chin Bin ^b   Wang, Yun Han ^a   Lin, Hui Lan ^c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT; PROCHLORPERAZINE; PROCHLORPERAZINE MALEATE; QUETIAPINE; RISPERIDONE; SEROTONIN 2A AGONIST; SULPIRIDE;

ACUTE RESPIRATORY FAILURE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG SAFETY; DRUG USE; EMERGENCY CARE; HEART FAILURE; HUMAN; IDIOPATHIC DISEASE; LUNG CANCER; MAJOR CLINICAL STUDY; PILOT STUDY; PRESCRIPTION; RESPIRATORY FAILURE; RISK; RISK ASSESSMENT; SIDE EFFECT; ADULT RESPIRATORY DISTRESS SYNDROME; CASE CONTROL STUDY; CHEMICALLY INDUCED; COHORT ANALYSIS; COMPLICATION; CROSSOVER PROCEDURE; FEMALE; LONGITUDINAL STUDY; MALE; MIDDLE AGED; TAIWAN;

AGED; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK; TAIWAN;

EID: 85014644913     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2016.3793     Document Type: Article

References (40)

1. World Health Organization. Chronic respiratory diseases: burden of COPD. http://www.who.int/respiratory/copd/burden/en/. Accessed March 3, 2016.
2. Soriano JB, Rodríguez-Roisin R. Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation. Proc Am Thorac Soc. 2011;8(4):363-367.
3. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053): 1459-1544.
4. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.
5. Calverley PM. Respiratory failure in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2003;47:26s-30s.
6. Chu CM, Chan VL, Lin AW, Wong IW, Leung WS, Lai CK. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax. 2004;59(12):1020-1025.
7. Dixit D, Bridgeman MB, Andrews LB, et al. Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients. Pharmacotherapy. 2015;35(6): 631-648.
8. Freudenmann RW, Süssmuth SD, Wolf RC, Stiller P, Schönfeldt-Lecuona C. Respiratory dysfunction in sleep apnea associated with quetiapine. Pharmacopsychiatry. 2008;41(3):119-121.
9. Peek DF. A patient with haloperidol induced laryngeal dystonia. Acta Anaesthesiol Belg. 2008; 59(2):103-105.
10. Yagmur F, Ulusoy HB, Buyukoglan H, Kaya MG. Acute respiratory distress due to antipsychotic drugs. Pharmacopsychiatry. 2010;43(3):118-119.
11. Acri AA, Henretig FM. Effects of risperidone in overdose. Am J Emerg Med. 1998;16(5):498-501.
12. Akyol A, Senel AC, Ulusoy H, Karip F, Erciyes N. Delayed respiratory depression after risperidone overdose. Anesth Analg. 2005;101(5):1490-1491.
13. Johnson MD, Newman JH, Baxter JW. Neuroleptic malignant syndrome presenting as adult respiratory distress syndrome and disseminated intravascular coagulation. South Med J. 1988;81(4):543-545.
14. Soriano FG, Vianna Edos S, Velasco IT. Neuroleptic-induced acute respiratory distress syndrome. Sao Paulo Med J. 2003;121(3):121-124.
15. Strachan PM, Benoff BA. Mental status change, myoclonus, electrocardiographic changes, and acute respiratory distress syndrome induced by quetiapine overdose. Pharmacotherapy. 2006;26 (4):578-582.
16. Wilson H, Ridley S. Antipsychotic drugs and the acute respiratory distress syndrome. Br J Anaesth. 2007;99(2):301-302.
17. Jabeen S, Polli SI, Gerber DR. Acute respiratory failure with a single dose of quetiapine fumarate. Ann Pharmacother. 2006;40(3):559-562.
18. Mouallem M, Wolf I. Olanzapine-induced respiratory failure. Am J Geriatr Psychiatry. 2001;9 (3):304-305.
19. Schatzberg AF, Nemeroff CB. Textbook of Psychopharmacology. 4th ed. Arlington, VA: The American Psychiatric Publishing; 2009.
20. Kuehn BM. APA targets unnecessary antipsychotic use. JAMA. 2013;310(18): 1909-1910.
21. Torres-Sánchez I, Rodríguez-Alzueta E, Cabrera-Martos I, López-Torres I, Moreno-Ramírez MP, Valenza MC. Cognitive impairment in COPD: a systematic review. J Bras Pneumol. 2015;41(2): 182-190.
22. Zhang MW, Ho RC, Cheung MW, Fu E, Mak A. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry. 2011;33(3): 217-223.
23. Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Respir Care. 2013;58(5):858-866.
24. Kuehn BM. FDA: antipsychotics risky for elderly. JAMA. 2008;300(4):379-380.
25. Wang MT, Lo YW, Tsai CL, et al. Statin use and risk of COPD exacerbation requiring hospitalization. Am J Med. 2013;126(7):598-606.e2.
26. Mapel D, Schum M, Yood M, Brown J, Miller D, Davis K. Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators. Prim Care Respir J. 2010;19(2): 109-117.
27. National Health Insurance Administration, Ministry of Health and Welfare. Enrollment status alteration and termination file [in Chinese]. http://www.nhi.gov.tw/webdata/webdata.aspx?menu =19&menu-id=774&webdata-id=3466. Accessed February 19, 2016.
28. Lien HM, Chou SY, Liu JT. Hospital ownership and performance: evidence from stroke and cardiac treatment in Taiwan. J Health Econ. 2008;27(5): 1208-1223.
29. Roth BL, Lopez E, Beischel S, Westkaemper RB, Evans JM. Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery. Pharmacol Ther. 2004;102(2): 99-110.
30. Bhardwaj H, Bhardwaj B, Awab A. Revisiting opioid overdose induced acute respiratory distress syndrome. Indian J Crit Care Med. 2014;18(2):119-120.
31. Lee LA, Caplan RA, Stephens LS, et al. Postoperative opioid-induced respiratory depression: a closed claims analysis. Anesthesiology. 2015;122(3):659-665.
32. Bjerre LM, LeLorier J. Expressing the magnitude of adverse effects in case-control studies: "the number of patients needed to be treated for one additional patient to be harmed." BMJ. 2000;320(7233):503-506.
33. Viemari JC, Tryba AK. Bioaminergic neuromodulation of respiratory rhythm in vitro. Respir Physiol Neurobiol. 2009;168(1-2):69-75.
34. Jiao YG, Li GC, Chen JP, Wu ZH, Zhang HT. Dopamine receptor 1 modulates the discharge activities of inspiratory and biphasic expiratory neurons via cAMP-dependent pathways. Cell Mol Neurobiol. 2013;33(2):155-160.
35. Dutschmann M, Bischoff AM, Büsselberg D, Richter DW. Histaminergic modulation of the intact respiratory network of adult mice. Pflugers Arch. 2003;445(5):570-576.
36. Horner RL. The neuropharmacology of upper airway motor control in the awake and asleep states: implications for obstructive sleep apnoea. Respir Res. 2001;2(5):286-294.
37. Nosè M, Recla E, Trifirò G, Barbui C. Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studies. Pharmacoepidemiol Drug Saf. 2015;24(8):812-820.
38. Partti K, Vasankari T, Kanervisto M, et al. Lung function and respiratory diseases in people with psychosis: population-based study. Br J Psychiatry. 2015;207(1):37-45.
39. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during the perioperative period. Anesthesiology. 1993;78(1): 56-62.
40. Scuderi PE, Conlay LA. Postoperative nausea and vomiting and outcome. Int Anesthesiol Clin. 2003;41(4):165-174.